Skip to main content

Farrow Jeffrey S's Form 4 filing

Global Blood Therapeutics, Inc.GBT · filed Sep 6, 2022

Accession no.
0000899243-22-030475
Filed
Sep 6, 2022
Trade date
Sep 1, 2022
Filing delay
5 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $2.14M. It was filed 5 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Farrow Jeffrey SCIK 0001405253Officer (Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 1, 2022Common StockMOption exerciseAcquired+2,763–F1–34,204Direct
Sep 1, 2022Common StockMOption exerciseAcquired+2,208–F1–36,412Direct
Sep 1, 2022Common StockFTax withholdingDisposed−1,885$68.15−$128,462.7534,527Direct
Sep 1, 2022Common StockSSaleDisposed−31,441$68.00−$2,137,9883,086Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 1, 2022Common StockMOption exerciseDisposed−2,763$0.00$013,814Direct
Sep 1, 2022Common StockMOption exerciseDisposed−2,208$0.00$015,460Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

Referenced by the price of 2 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)